2021 U.S.-Booked Air Volume: $11.5 million
Edwards Lifesciences’ U.S.-booked air volume in 2020 was
$11.5 million, according to a BTN estimate, compared with an estimated $8.6
million in 2020.
The medical technology company’s selling, general and
administrative expenses in the fourth quarter of 2021 jumped 25 percent from
the same quarter in 2020 to $424 million, representing 31.9 percent of sales.
The increase partially was due to the return of two medical congresses after a
2020 in which large meetings were banned. These events negated some of the
savings from reduced travel spending reported in the first quarter of 2021.
As part of its sustainability initiatives Edwards is
targeting carbon neutrality by 2030. By sourcing materials as close as possible
to its manufacturing sites, the company exceeded its 2021 target of reducing
product distribution air miles traveled by 3 million from a 2018 baseline. A
new target has been set to save by 2023 an additional 1.5 million air miles
from 2018.
Edwards has over 16,000 employees. Overall sales for the company rose 19
percent to $5.2 billion in 2021 versus the prior year. The company acquired
Ceres Technologies in July 2022.